Auricular Acupuncture for Pain Relief After Ambulatory Knee Arthroscopy
This study has been completed.
Information provided by:
University Medicine Greifswald
First received: October 5, 2005
Last updated: February 25, 2011
Last verified: February 2011
The aim was to investigate whether auricular acupuncture is superior to sham acupuncture in relief of acute postoperative pain and in reduction of analgesics consumption on demand and their side effects in patients after ambulatory knee arthroscopy
Procedure: Auricular acupuncture
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
||Auricular Acupuncture Versus Placebo (Sham Acupuncture) for Postoperative Pain Relief After Ambulatory Knee Arthroscopy - a Randomized Controlled Trial
Primary Outcome Measures:
- Postoperative ibuprofen requirement after the surgery
Secondary Outcome Measures:
- Pain intensity assessed by patients on VAS-100 ; total piritramide requirement in anesthesia recovery room; incidence of analgesia-related side effects
| Estimated Enrollment:
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||July 2004 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||16 Years to 65 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- Patients with an American Society of Anesthesiologists physical status of I to II scheduled for ambulatory knee arthroscopy under general anesthesia.
- Surgery time does not exceed 60 minutes.
- Patients without previous opioid and/or psychiatric medication.
- Patients ranged 16-65 years old.
- Patients able to use Visual Analogue Scale-100 for pain intensity measurement.
- Patients who have given informed consent.
- Pregnant or nursing females.
- Recidivist alcoholics and/or patients with history of psychiatric disease.
- Local or systemic infection.
- Age < 16 and > 65 years.
- Surgery time more than 60 minutes.
- Inability to use Visual Analogue Scale-100.
- Patients consumed opioid medication before surgery.
- Patients with prosthetic or damaged cardiac valves (s. Potential risks)
- Patients who are unable to understand the consent form.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00233857
|Anesthesiology and Intensive Care Medicine Department, University of Greifswald, Germany
|Greifswald, Germany, 17487 |
University Medicine Greifswald
||Taras I. Usichenko, Assistant Professor
||Anesthesiology and Intensive Care Medicine Department, Ernst Moritz Arndt University of Greifswald, Germany
No publications provided
History of Changes
|Other Study ID Numbers:
||III UV 23/03
|Study First Received:
||October 5, 2005
||February 25, 2011
||European Union: European Medicines Agency
Keywords provided by University Medicine Greifswald:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on June 29, 2015
Signs and Symptoms